These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17667473)

  • 1. Psychosis associated with fluoxetine in Prader-Willi syndrome.
    Hergüner S; Motavalli Mukaddes N
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):944-945. PubMed ID: 17667473
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of fluoxetine to modify the skin-picking behaviour of Prader-Willi syndrome.
    Schepis C; Failla P; Siragusa M; Palazzo R; Romano C
    Australas J Dermatol; 1998 Feb; 39(1):57-8. PubMed ID: 9529694
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
    Kohn Y; Weizman A; Apter A
    Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [To know more about the Prader-Willi syndrome. Diagnosis].
    Midro AT; Olchowik B; Lebiedzińska A; Midro H
    Psychiatr Pol; 2009; 43(2):135-49. PubMed ID: 19697784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome.
    Vogels A; Matthijs G; Legius E; Devriendt K; Fryns JP
    J Med Genet; 2003 Jan; 40(1):72-3. PubMed ID: 12525547
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent brief depression in Prader-Willi syndrome: a case report.
    Watanabe H; Ohmori O; Abe K
    Psychiatr Genet; 1997; 7(1):41-4. PubMed ID: 9264138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment.
    Soni S; Whittington J; Holland AJ; Webb T; Maina E; Boer H; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):32-42. PubMed ID: 17181601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problem behaviors associated with deletion Prader-Willi, Smith-Magenis, and cri du chat syndromes.
    Clarke DJ; Boer H
    Am J Ment Retard; 1998 Nov; 103(3):264-71. PubMed ID: 9833657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.
    Dykens E; Shah B
    CNS Drugs; 2003; 17(3):167-78. PubMed ID: 12617696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prader-Willi and snoRNAs.
    Peters J
    Nat Genet; 2008 Jun; 40(6):688-9. PubMed ID: 18509309
    [No Abstract]   [Full Text] [Related]  

  • 12. Topiramate effectiveness in Prader-Willi syndrome.
    Smathers SA; Wilson JG; Nigro MA
    Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of childhood disorders: XV. Prader-Willi syndrome: genes, brain, and behavior.
    State MW; Dykens EM
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):797-800. PubMed ID: 10846317
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome.
    Araki S; Ohji T; Shiota N; Dobashi K; Shimono M; Shirahata A
    Pediatr Int; 2010 Feb; 52(1):e1-3. PubMed ID: 20158635
    [No Abstract]   [Full Text] [Related]  

  • 15. Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype.
    Milner KM; Craig EE; Thompson RJ; Veltman MW; Thomas NS; Roberts S; Bellamy M; Curran SR; Sporikou CM; Bolton PF
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1089-96. PubMed ID: 16178933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal hypotonia in Prader-Willi syndrome due to t(15;16)].
    Fernández-Novoa MC; Vargas MT; Santano MR; Moya J; Garnacho MC
    Rev Neurol; 2000 Sep 1-15; 31(5):499-500. PubMed ID: 11027108
    [No Abstract]   [Full Text] [Related]  

  • 17. Prader--Willi syndrome: 16-year experience in Hong Kong.
    Lo IF; Luk HM; Tong TM; Lai KK; Chan DH; Lam AC; Chan DK; Hau EW; Fung CO; Lam ST
    J Genet Genomics; 2012 Apr; 39(4):191-4. PubMed ID: 22685788
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic and clinical advances in Prader-Willi syndrome.
    Wharton RH; Loechner KJ
    Curr Opin Pediatr; 1996 Dec; 8(6):618-24. PubMed ID: 9018447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human genome: detecting chromosomal deletions: Angelman and Prader-Willi syndromes.
    Morris-Rosendahl DJ; Back E
    Am J Psychiatry; 2002 Mar; 159(3):372. PubMed ID: 11869997
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary Retention in an Adolescent Patient Caused by Fluoxetine Alone.
    Karadag M; Gokcen C; Bayar H; Aksoy I
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):658. PubMed ID: 26485088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.